Timothy A Springer bought $10.1M of Tectonic Therapeutic (TECX)

Executed Oct 22 2024, disclosed Oct 24 2024, 2 days later.

Value, as filed

$10.1M

300,000 sh × $33.59

Executed

Oct 22 2024

the trade date, as filed

Disclosed

Oct 24 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+29.7%

+11.0% from execution

Over the 21 trading sessions from the disclosed entry session (Oct 24 2024), the stock returned +29.7% (delay-adjusted); from the execution session (Oct 22 2024), +11.0%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

TS Timothy A Springer Director profile →

Timothy A Springer (Director) filed 11 Form 4 reports in the past 24 months (11 purchases, 0 sales), most often in RNAC. Across 11 priced purchase filings, the average 21-session return was +8.0% from execution and +3.1% from disclosure (delay-adjusted; derived). The largest single filing was $40.0M of TECX (789,294 sh across 2 lots, as filed), executed Feb 5 2025.

The name

TECX TECX TECX · 10 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Timothy A Springer in TECX

TECXPURCHASE Tectonic Therapeutic, Inc. $2.2M
133,349 sh across 5 lots
Exec Apr 9 2025
Filed Apr 11 2025 · 5:30 PM ET TECXPURCHASE Tectonic Therapeutic, Inc. $8.6M
500,000 sh across 2 lots
Exec Apr 7 2025
Filed Apr 9 2025 · 5:30 PM ET TECXPURCHASE Tectonic Therapeutic, Inc. $40.0M
789,294 sh across 2 lots
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET TECXPURCHASE Tectonic Therapeutic, Inc. $1.4M
47,600 sh across 3 lots
Exec Sep 26 2024
Filed Sep 26 2024 · 5:30 PM ET